Calcipotriene vs Skyrizi

Calcipotriene: A vitamin D-like cream or ointment for plaque psoriasis. It slows the overgrowth of skin cells that makes plaques thick and scaly, and it is not a steroid. Skyrizi: An injected biologic for moderate to severe plaque psoriasis. It blocks interleukin-23, a signal that sits high up in the psoriasis chain, and after two starting doses it is given about four times a year.

Reviewed by Dr. Schwarz, Board-Certified Dermatologist
Calcipotriene — Header ImageSkyrizi shown in recognizable white injection pen with blue and turquoise accents.

Which one is right for you?

Choose Calcipotriene if…

Choose for long-term psoriasis control without a steroid, often after a short combined course settles redness.

  • Thick, scaly plaques on body or scalp
  • You want a non-steroid for ongoing use
  • Psoriasis covers less than a third of your skin

Choose Skyrizi if…

Choose for moderate to severe psoriasis when you want high clearance with only about four injections a year.

  • Moderate to severe plaque or scalp psoriasis
  • You want infrequent injections
  • No active TB
Often combined

Can you take them together?

Calcipotriene is often used on remaining patches while on Skyrizi. It does not interact with the biologic.

At a glance

● Calcipotriene
● Skyrizi
Type
Vitamin D analogue (not a steroid)
Biologic injection (risankizumab, IL-23 blocker)
What it does
Slows the overgrowth of skin cells in plaques
Blocks IL-23, high up in the psoriasis chain
Best for
Plaque psoriasis, including scalp
Moderate to severe plaque psoriasis and psoriatic arthritis
Prescription
Yes
Yes
Form
Ointment, cream, solution or foam
Injection under the skin
How often
Twice daily (once daily in combinations)
Weeks 0 and 4, then every 12 weeks
Course length
Ongoing, between steroid courses
Ongoing
Time to results
6–8 weeks
16 weeks
Main side effect
Stinging or burning at first
Colds; injection-site reactions
Blood tests
None at usual amounts
TB test before starting
Pregnancy
Check with your clinician
Check with your clinician
Cost
Low; generic available
High; no generic

What it treats

Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.

Evidence level
Calcipotriene
Skyrizi
Strong evidenceMost established uses
Two thick, sharply bordered plaques on a knee on fair light skin. They are salmon-pink to red with loose silvery-white scale on top.

Psoriasis

Thins plaques, best with a steroid.
Two thick, sharply bordered plaques on a knee on fair light skin. They are salmon-pink to red with loose silvery-white scale on top.

Psoriasis

Clears or nearly clears skin in most patients.
Parted hair on fair scalp skin showing a raised salmon-pink plaque topped with dry silvery-white scale, with a sharply drawn border against normal skin.

Scalp Psoriasis

Improves scalp plaques.
Psoriatic Arthritis on light skin.

Psoriatic Arthritis

Reduces joint symptoms.
Moderate evidenceSome supportive research
Parted hair on fair scalp skin showing a raised salmon-pink plaque topped with dry silvery-white scale, with a sharply drawn border against normal skin.

Scalp Psoriasis

Solutions reduce scale.
—
Limited evidenceEarly or small studies
The front of a forearm on fair skin. Two pale patches with sharp edges sit against lightly tanned skin, and the difference between the patch and the skin around it is subtle.

Vitiligo

Sometimes added to light therapy.
—
Little evidence
Salmon-pink patches with fine greasy yellowish scale in the crease beside the nose and through the eyebrow on fair skin, with soft edges that fade into normal skin.

Seborrheic Dermatitis

Not a standard treatment.
An inflamed lump in the armpit on fair skin. The skin over it is swollen, shiny and red, with a pair of small blackhead-like openings in the skin beside it.

Hidradenitis Suppurativa

Trials were disappointing.
Not effective
—
Extreme close-up of light skin in an active eczema flare, too close to tell which part of the body it is. Blotchy pink-red inflammation covers the whole frame with no clear edge, with small raised bumps, fine dry scale and a few fresh scratch marks.

Eczema

Doesn't target eczema inflammation.
Can make it worse
Extreme close-up of light skin in an active eczema flare, too close to tell which part of the body it is. Blotchy pink-red inflammation covers the whole frame with no clear edge, with small raised bumps, fine dry scale and a few fresh scratch marks.

Eczema

Irritates eczema.
—
How it works

Calcipotriene

Calcipotriene. Helps psoriasis skin cells grow and mature more normally. 1. Activates vitamin D receptors: Changes signals inside skin cells. 2. Slows excess cell growth: Helps reduce the rapid buildup seen in psoriasis. 3. Improves cell maturation: Helps cells develop into more normal skin layers. 4. Reduces plaque scale: Thick, scaly patches gradually become flatter.
Open full-size diagram
Diagram explanation and sources

Activates vitamin D receptors: Changes signals inside skin cells. Slows excess cell growth: Helps reduce the rapid buildup seen in psoriasis. Improves cell maturation: Helps cells develop into more normal skin layers. Reduces plaque scale: Thick, scaly patches gradually become flatter.

Calcipotriene is a vitamin D analog with effects on cell proliferation and differentiation. Its complete antipsoriatic mechanism is not established; this is a simplified overview.

Source 1 · Source 2

Skyrizi

Skyrizi. Risankizumab interrupts the IL-23 psoriasis pathway. 1. Blocks IL-23: Binds this immune messenger before it reaches its receptor. 2. Turns down inflammatory T cells: Reduces signals that keep the psoriasis cycle active. 3. Helps plaques clear: Excess skin buildup and inflammation gradually decrease.
Open full-size diagram
Diagram explanation and sources

Blocks IL-23: Binds this immune messenger before it reaches its receptor. Turns down inflammatory T cells: Reduces signals that keep the psoriasis cycle active. Helps plaques clear: Excess skin buildup and inflammation gradually decrease.

Risankizumab selectively targets the p19 subunit of IL-23, not IL-12. The T-cell and skin changes are a simplified downstream interpretation.

Source 1

How you take it

Treatment plan

When to Apply: Twice a day for the plain product, thinly onto the plaques only. Once a day for the combined calcipotriene-and-steroid products. Do not use more than about 100 grams a week, and do not treat more than roughly a third of the body surface. With phototherapy, apply it after the session, not before.

How to Start: Full dose from day one, on the plaques only. Many start on a combined calcipotriene-and-steroid product for the first few weeks to settle redness, then continue on calcipotriene alone.

If It Irritates: Burning and stinging in the first days is usual and often settles. Moisturizer first, or once a day for a week, helps. Irritation on the face, eyelids, groin or under the breasts is not one to push through — thin skin, and this drug is not made for it. Sharp burning on broken skin means waiting for it to close over.

If It’s Not Working: There is only one strength, so nothing can be increased. Give it six to eight weeks. If plaques are still thick, the next steps are the combined product with a steroid, switching cream for ointment, adding phototherapy, or a tablet or injection. Also check what else is going on the skin — salicylic acid inactivates calcipotriene.

Two starting doses close together, then a long steady interval. Not adjusted for body weight.

Starting dose: 150 mg as one injection.

Second dose: 150 mg, four weeks after the first.

Usual dose: 150 mg every 12 weeks — about four injections a year after the first year.

If it stops working: There is no approved higher dose or shorter interval for psoriasis. Losing response means reviewing the diagnosis, not injecting more often.

How long: Long term, with no set end point, while it works and is tolerated.

Monitoring

No routine blood tests when it is used normally: plaques only, within the weekly amount, healthy kidneys.

The one thing watched for is raised blood calcium. It is rare, and it comes from using far more than recommended, treating very large areas, or kidney disease that stops the body clearing the extra calcium. Calcium may be checked if any of those apply, or if you take high-dose vitamin D or calcium supplements. Symptoms are unusual thirst, passing more urine than usual, nausea, constipation, muscle weakness and confusion.

Monitoring is otherwise clinical — the skin at six to eight weeks, and how much of a tube is used per week. With the combined steroid product, the review also covers how long the steroid has run.

Long term, calcipotriene alone is a drug you can stay on. Nothing accumulates and it does not thin skin, which is why it is the usual maintenance between steroid courses.

Everyone is screened for tuberculosis before the first dose — a skin test or TB blood test, plus a chest X-ray if that is positive. Dormant TB is treated first. This class probably carries less TB risk than the TNF blockers, but screening is not optional.

Hepatitis B and C are usually checked at the same time.

After that there is no fixed blood test schedule. Risankizumab does not need the regular liver and blood count testing methotrexate does. Monitoring is clinical: the skin, whether infections are more frequent, whether the dose dates are kept. TB testing is repeated yearly or by exposure risk.

There is no boxed warning. The most common side effects reported are upper respiratory infections, headache, tiredness, fungal skin infections and injection site reactions. Serious allergic reactions are rare but are why the first dose is often given with someone trained nearby.

When to take it
Not covered in this guide yet

Any time of day. The calendar matters more here than with a weekly drug. Twelve weeks is long enough that people lose track, so put every dose date in your phone and book the next reminder the day you inject.

Take it out of the fridge 15 to 30 minutes before and let it warm on the counter. Cold liquid stings. No hot water, no microwave.

Inject into the front of the thigh or the belly, at least two inches from the navel. The back of the upper arm works if someone else is doing it. Rotate the site, avoid skin that is bruised, tender, hard or scarred, and never inject through a plaque. Ask for training before the first dose. Used devices go in a sharps container.

If you miss a dose
Not covered in this guide yet

Inject as soon as you remember, then count twelve weeks from that day. If it has been much longer than twelve weeks, call the prescriber first so the schedule can be reset.

When you’ll see results

Approximate windows, not promises.

● Calcipotriene
● Skyrizi
First few minutes

First few minutesApplying it: Stinging or burning, if it happens, is worst at the start and eases.

First few minutesThe injection: A sharp sting for a few seconds, then redness or a small welt. Settles within a day or two.

Weeks 1 to 2

Weeks 1 to 2Starting: Early flattening and less scale. Its strongest effect, and what people notice first.

Weeks 2 to 6

Weeks 2 to 6The steady phase: Plaques thin and the silvery scale falls away. Redness fades more slowly than thickness, the main reason calcipotriene and a steroid are combined. Itch improves, slower than with a steroid.

Weeks 6 to 8

Weeks 6 to 8Judge it here: Roughly where the effect plateaus in trials.

Scalp

ScalpWhere it is used most: The scalp solution and the combined foam or gel work well here.

Long term

Long termMaintenance: Used between steroid courses, it holds the result. Stopped, plaques return over weeks to months.

Weeks 1 to 4

Weeks 1 to 4Starting: Itch settles first. Scale lifts and plaques thin.

Weeks 4 to 16

Weeks 4 to 16Working: Most of the change happens here, from the second dose on. Plaques flatten and redness fades from the middle out, often leaving a paler or darker mark.

Week 16

Week 16Judge it here: Most people reached 90 percent clearer skin, and many were clear or nearly clear. Joints improve on the same timeline.

3 to 6 months

3 to 6 monthsScalp, palms and soles: Slower than the trunk and limbs.

6 to 12 months

6 to 12 monthsNails: Last to change, because a nail takes months to grow out.

Between doses

Between dosesSteady state: Most people notice no dip. If plaques reliably return in the last few weeks, say so.

Side effects

Sorted by what to do about them.

Calcipotriene

Skyrizi

Common
Common
  • Stinging or burning in the first days
  • Redness or itch around plaques
Common
  • Colds and upper respiratory infections
  • Headache, tiredness
  • Injection-site reactions
Tell your doctor
Tell your doctor
  • Irritation on the face or skin folds
Tell your doctor
  • Persistent cough or night sweats
Stop and get care
Stop and get care
  • Unusual thirst, passing more urine, nausea, weakness or confusion (high calcium)
Stop and get care
  • Fever with serious infection
  • Swelling of face or throat

Safety and who should avoid it

Pregnancy
Use care
Ask the doctor managing your pregnancy.
Use care
Discuss with your clinician.
Breastfeeding
Use care
Keep it off the chest.
Use care
Discuss with your clinician.
Children
Use care
Smaller amounts; specialist guidance.
Not used
Adults for psoriasis.
Monitoring
Use care
Calcium checks only with kidney disease or very large amounts.
Sometimes
TB test before starting; liver tests for Crohn's dosing.
Key interactions
Check
Salicylic acid inactivates it; apply after, not before, light therapy; high-dose vitamin D or calcium.
Check
Avoid live vaccines.
Other cautions
Avoid
More than 100 g a week; face and folds; erythrodermic or pustular psoriasis.
Avoid
Active TB or serious infection.

Cost and getting it

Getting it and cost

Generic calcipotriene is cheap and widely available; cost is rarely the barrier for the plain ointment or cream.

The branded combination products, and the foam and suspension forms, cost substantially more and often need prior authorization. Plans usually want a topical steroid, and often generic calcipotriene, tried first.

If cost decides it, generic ointment or cream plus a separate generic steroid does much the same job, at the price of two tubes.

The list price runs to tens of thousands of dollars a year. Almost nobody pays that; what you pay depends on your plan.

It is brand only — no generic, no biosimilar — so there is no cheaper equivalent to switch to. That is a real difference from adalimumab.

Prior authorization is close to universal. Most plans require documented failure of something cheaper first — phototherapy, methotrexate, sometimes another biologic. Denials are usually about missing records rather than the drug, and appeals succeed reasonably often when the history is documented.

Manufacturer copay cards can cut the cost to very little with commercial insurance. By law they cannot be used with Medicare or Medicaid. For those plans, or no insurance, the manufacturer's patient assistance program and independent foundations are the usual routes. Terms change often.

One practical note: because doses are twelve weeks apart, a change of insurance or a formulary switch in January can land in the middle of a dosing gap. Check coverage before the next dose is due, not the week it is.

When you stop

Comes back?
Plaques return over weeks to months — psoriasis is long-term.
Psoriasis returns slowly, often over many months.
Taper needed?
No taper and no withdrawal.
No.
After the last dose
Often restarted as maintenance between steroid courses.
Restarting usually works again.

Common questions

Calcipotriene:Is calcipotriene a steroid?

No. A vitamin D analog. It does not thin skin, which is why it can be used long term and is often the maintenance treatment after a steroid course.

Calcipotriene:Can I use it on my face?

No. The face, eyelids, groin and under the breasts all sting badly — thin skin. Ask about a different product for those areas.

Calcipotriene:How much can I use?

About 100 grams a week, and about a third of the body surface. That limit keeps blood calcium from rising.

Calcipotriene:Why does it burn?

Irritation is the most common side effect, worst in the first days. Moisturizer first, or once a day for a week or two, settles it.

Calcipotriene:Can I use a salicylic acid scale remover with it?

Not at the same time. Salicylic acid inactivates calcipotriene. Keep them well apart in the day or ask about an alternative.

Calcipotriene:Do I need blood tests?

Not for normal use with healthy kidneys. Calcium may be checked with kidney disease, very large amounts, or high-dose vitamin D.

Skyrizi:What does biologic mean?

A large protein grown in living cells rather than a chemical made in a factory. That is why it is injected, and why it lives in the fridge.

Skyrizi:Really only four injections a year?

After the first two doses, four weeks apart, yes. The drug stays in the body long enough that the gap can be twelve weeks.

Skyrizi:Does the injection hurt?

A few seconds of stinging. Letting it warm to room temperature first makes a noticeable difference.

Skyrizi:Do I need blood tests while I am on it?

Tuberculosis and hepatitis before you start, and TB testing often repeated yearly. Beyond that, no routine schedule.

Skyrizi:What happens if I am late with a dose?

Inject when you remember and count twelve weeks from that day. If you are weeks or months late, call first.

Skyrizi:Can I have vaccines?

Yes, apart from live ones. The flu shot, COVID vaccines and Shingrix are not live. Have any live ones before starting.

Dermapedia on YouTube